C07K 14/5446
Il-16
Official title: {il-16}
C07K14/5446 (Il-16) appears on 33 US grants and 23 published applications in this corpus.
Search patents in C07K- Granted patents
- 33
- Published applications
- 23
- Assignees
- 14
- Inventors
- 38
- Latest grant
- 14 May 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1997 | 1 | 0 |
| 1998 | 3 | 0 |
| 1999 | 4 | 0 |
| 2000 | 1 | 0 |
| 2001 | 1 | 0 |
| 2002 | 3 | 0 |
| 2003 | 1 | 1 |
| 2004 | 1 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 1 | 1 |
| 2008 | 0 | 0 |
| 2009 | 1 | 0 |
| 2010 | 0 | 2 |
| 2011 | 1 | 1 |
| 2012 | 0 | 1 |
| 2013 | 0 | 1 |
| 2014 | 1 | 0 |
| 2015 | 1 | 1 |
| 2016 | 0 | 0 |
| 2017 | 1 | 1 |
| 2018 | 0 | 1 |
| 2019 | 6 | 4 |
| 2020 | 0 | 2 |
| 2021 | 2 | 2 |
| 2022 | 1 | 1 |
| 2023 | 2 | 3 |
| 2024 | 1 | 1 |
By publication year. Applications have been published since 2001.
Recent patents
- CCR5 and CD4 siRNA-targeted phospholipid nanosomes therapeutics for treatment of HIV-1 and other diseases14 May 2024US 11,981,714 B2
- Cellular populations and uses thereof30 May 2023US 11,662,343 B2The Council of the Queensland Institute of Medical Research
- Combinations of mRNAs encoding immune modulating polypeptides and uses thereof7 Mar 2023US 11,596,609 B2ModernaTX, Inc.
- Combinations of mRNAs encoding immune modulating polypeptides and uses thereof31 May 2022US 11,344,504 B1ModernaTX, Inc.
- Combinations of mRNAs encoding immune modulating polypeptides and uses thereof30 Nov 2021US 11,185,510 B2ModernaTX, Inc.
- Cellular populations and uses thereof19 Dec 2024US 2024/0418705 A1The Council of the Queensland Institute of Medical Research
- Cellular populations and uses thereof12 Oct 2023US 2023/0324369 A1The Council of the Queensland Institute of Medical Research
- Combinations of mrnas encoding immune modulating polypeptides and uses thereof9 Feb 2023US 2023/0041964 A1ModernaTX, Inc.
- Combinations of mrnas encoding immune modulating polypeptides and uses thereof26 Jan 2023US 2023/0026381 A1ModernaTX, Inc.
- CCR5 and CD4 siRNA-Targeted Phospholipid Nanosomes Therapeutics for Treatment of HIV-1 and Other Diseases12 May 2022US 2022/0144629 A1
Most cited
By later US patents
- Protein having interleukin 13 activity, recombinant DNA coding for this protein, transformed cells and microorganisms43US 5,652,123 A1997
- Method of identifying compounds capable of activating ISL production18US 6,383,739 B1Budesrepublik Deutschland Vertreten Durch Den Bundesminister · 2002
- Combinations of mRNAs encoding immune modulating polypeptides and uses thereof16US 10,172,808 B2ModernaTX, Inc. · 2019
- Combinations of mRNAs encoding immune modulating polypeptides and uses thereof13US 10,285,950 B2ModernaTX, Inc. · 2019
- Lymphocyte chemoattractant factor and uses thereof9US 5,766,866 AResearch Corporation Technologies, Inc. · 1998